FDA's Drug Approval Process: Up to the Challenge? : Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, First Session, on Examining Food and Drug Administration's (FDA) Drug Approval Process, Focusing on FDA's Drug Approval Process After a Sponsor Demonstrates that Their Benefits Outweigh Their Risks for a Specific Population and Use, and that the Drug Meet [sic] Meets Standards for Safety and Efficacy, March 1, 2005
U.S. Government Printing Office, Jan 1, 2005 - Drugs - 93 pages
Try this search over all volumes: tients
Results 1-0 of 0
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
AACAP Adolescent Psychiatry adverse drug reactions adverse events Advisory Committee agency antidepressants approved drugs assess authority to require Bextra black box warning cancer CDER CHAIRMAN child and adolescent children and adolescents clinical trials companies conduct Congress consumers Cox-2 inhibitors Davenport-Ennis depression detect disease doctors drug approval process drug products drug review drug safety drug safety issues ensure evaluation Fassler FDA need FDA's drug Fleming important improve increase KWEDER labeling changes medical products medicines monitoring NSAIDs Office of Drug patients PDUFA pediatric percent physicians population post-marketing postmarket studies potential prepared statement prescription drugs public health QUESTIONS OF SENATOR randomized trials regulatory safe and effective safety and efficacy safety risks safety signals scientific Scott Gottlieb Senator BURR Senator Enzi Senator KENNEDY Senator MURRAY side effects sponsor SSRI stroke testimony Thank therapies tients tion treatment options user fees Vioxx